Inventor · disambiguated record
Michael J. Zacuto
Also filed as: ZACUTO MICHAEL · ZACUTO MICHAEL J
11 granted patents·14 citations·filing 2009–2024
84Inventor score
Top patents by PatentIndex Score
11 records- 0187US9120818B2Process and intermediates for preparing macrolactamsCHEN CHENG·Filed 2011·Granted Sep 1, 2015·8 cites·20 claims
- 0286US12435028B2Processes for the preparation of (S)-tert-butyl 4,5-diamino-5-oxopentanoateCELGENE CORP·Filed 2024·Granted Oct 7, 2025·0 cites·6 claims
- 0381US11912644B2Processes for the preparation of (S)-tert-butyl 4,5-diamino-5-oxopentanoateCELGENE CORP·Filed 2022·Granted Feb 27, 2024·0 cites·19 claims
- 0471US9187488B2Process for preparing chiral dipeptidyl peptidase-IV inhibitorsZACUTO MICHAEL J·Filed 2012·Granted Nov 17, 2015·3 cites·10 claims
- 0569US11505522B2Processes for the preparation of (S)-tert-butyl 4,5- diamino-5-oxopentanoateCELGENE CORP·Filed 2020·Granted Nov 22, 2022·0 cites·20 claims
- 0669US10717703B2Processes for the preparation of (S)-tert-butyl 4,5-diamino-5-oxopentanoateCELGENE CORP·Filed 2018·Granted Jul 21, 2020·0 cites·20 claims
- 0767US7902376B2Process for preparing chiral dipeptidyl peptidase-IV inhibitor intermediatesMERCK SHARP & DOHME·Filed 2009·Granted Mar 8, 2011·3 cites·12 claims
- 0865US11312699B2Processes for preparing 2-(4-chlorophenyl)-N-((2-(2,6-dioxopiperidin-3-yl)-1-oxoisoindolin-5-yl)methyl)-2,2-difluoroacetamideCELGENE CORP·Filed 2020·Granted Apr 26, 2022·0 cites·24 claims
- 0953US10053466B2Process for preparing chiral dipeptidyl peptidase-IV inhibitorsMERCK SHARP & DOHME·Filed 2017·Granted Aug 21, 2018·0 cites·5 claims
- 1052US9527855B2Process for preparing chiral dipeptidyl peptidase-IV inhibitorsMERCK SHARP & DOHME·Filed 2015·Granted Dec 27, 2016·0 cites·4 claims
- 1145US9862725B2Process for preparing chiral dipeptidyl peptidase-IV inhibitorsMERCK SHARP & DOHME·Filed 2015·Granted Jan 9, 2018·0 cites·7 claims
Join the waitlist — get patent alerts
Get an alert when Michael J. Zacuto files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →